Biopharma Daily Stock Updates - 01/21/21

$XBI $150.78 (-2.17%) 📉

COVID:

$VBIV (-6.53%) - VBI Vaccines Announces Progress of Coronavirus Vaccine Program

https://mail.google.com/mail/u/2/#inbox/FMfcgxwKkbldSnQJJCGqTmjpbtSTLWxK

$MRNA (+6.26%) - Moderna Announces First Participant Dosed in Phase 1/2 Study of Moderna COVID-19 Vaccine in Japan Led by Takeda

https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-first-participant-dosed-phase-12-study-moderna

PIPELINE:

$INMB (-18.95%) - INmune Bio, Inc. Announces XPro1595 Found to Decrease Neuroinflammation and Neurodegeneration Biomarkers in Patients with Alzheimer’s Disease in Phase 1b Trial

https://inmunebio.com/index.php/en/news-2/2021/446-muneioncnnouncesro1595oundtoecreaseeuro20210121

$AMRN (+1.77%) - ICOSAPENT ETHYL INCLUDED IN THE CHINESE SOCIETY OF CARDIOLOGY (CSC) UPDATED GUIDELINES FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASES

https://investor.amarincorp.com/news-releases/news-release-details/icosapent-ethyl-included-chinese-society-cardiology-csc-updated

$ORMP (+6.26%) - Oramed Doses Patients Across Multiple Sites in Phase 3 Oral Insulin Study

https://oramed.gcs-web.com/news-releases/news-release-details/oramed-doses-patients-across-multiple-sites-phase-3-oral-insulin

$CDAK (-5.41%) - Codiak’s Versatile engEx™ Platform for Engineered Exosomes Published in the Journal Molecular Therapy

https://ir.codiakbio.com/news-releases/news-release-details/codiaks-versatile-engextm-platform-engineered-exosomes-published

$HTRX (+0.11%) - Heron Therapeutics Announces Publication of Results from EPOCH 1 Follow-On Study of HTX-011 in Patients Undergoing Bunionectomy Surgery

https://herontherapeutics.gcs-web.com/news-releases/news-release-details/heron-therapeutics-announces-publication-results-epoch-1-follow

$SPRO (+3.14%) - Spero Therapeutics Announces Issuance of Allowance for a U.S. Patent Covering Lead Candidate Tebipenem HBr

https://investors.sperotherapeutics.com/news-releases/news-release-details/spero-therapeutics-announces-issuance-allowance-us-patent

FINANCIAL:

$EDIT (-11.11%) - Pricing of an underwritten offering of 3,500,000 shares of its common stock at a public offering price of $66.00 per share

https://ir.editasmedicine.com/news-releases/news-release-details/editas-medicine-announces-pricing-offering-common-stock-0

$PGEN (-2.87%) - Precigen Announces Proposed Public Offering of Common Stock

https://investors.precigen.com/news-releases/news-release-details/precigen-announces-proposed-public-offering-common-stock

$MRUS (+8.75%) - Pricing of an underwritten public offering of 4,848,485 common shares at a public offering price of $24.75 per share.

https://ir.merus.nl/news-releases/news-release-details/merus-announces-pricing-public-offering-common-shares-0

$ONCS (+23.09%) - Pricing of an underwritten public offering of 7,711,284 shares of its common stock at a price of $5.45 per share

https://ir.oncosec.com/press-releases/detail/2075/oncosec-medical-announces-pricing-of-42-0-million-public